Eli Lilly files quarterly report (10-Q) for the period ended Jun 30, 2026
Eli Lilly filed its quarterly report on Form 10-Q with the SEC on Aug 5, 2026, 2:40 PM ET, covering the quarter ended Jun 30, 2026. It reports fiscal Q2 2026 results.
- Revenue: $22.97B (+47.7% from $15.56B a year earlier)
- Net income: $7.09B (+25.3% from $5.66B a year earlier)
- Diluted EPS: $7.94 (+26.2% from $6.29 a year earlier)
- Form 10-Q accepted by EDGAR Aug 5, 2026, 2:40 PM ET
- Accession number 0000059478-26-000081
LLY around the story · hourly24 h reaction ▲ 2.47%
Source
SEC EDGARAug 5, 2026, 2:40 PM ET
SEC filing 10-Q · accession 0000059478-26-000081 · sec.gov ↗